Oregon Cancer

News and information for cancer services throughout Oregon.

  • Introducing Prevention4ME: A new era in breast cancer risk assessment and early detection

    Introducing Prevention4ME: A new era in breast cancer risk assessment and early detection

    Providence Breast Care and Breast Surgery Clinics launch Prevention4ME, a groundbreaking program to empower women with personalized breast cancer risk assessments and proactive screening options.

    Read Article
  • A precision oncology revolution is underway at Providence

    A precision oncology revolution is underway at Providence

    Celebrating World Cancer Day with a look at the work of Carlo Bifulco, M.D. as he helps lead advancements in AI-driven, accessible precision oncology at Providence Cancer Institute.

    Read Article
  • 2025 SITC Meeting: Three Providence researchers honored at 40th anniversary

    2025 SITC Meeting: Three Providence researchers honored at 40th anniversary

    Providence Cancer Institute researchers share important cancer research at SITC annual meeting and receive recognition for their contributions to science.

    Read Article
  • Transforming outcomes in AML and breast cancer: Three open trials at Providence

    Transforming outcomes in AML and breast cancer: Three open trials at Providence

    New studies at Providence Cancer Institute offer hope to patients with limited treatment options.

    Read Article
  • Oregon cancer leaders unite to discuss research and policy

    Oregon cancer leaders unite to discuss research and policy

    Providence Cancer Institute leader joined experts in cancer research, policy and advocacy to discuss current challenges and the future of research.

    Read Article
  • Lobular Breast Cancer: Exploring Current Knowledge and Advancing Understanding of This Understudied Disease.

    Lobular Breast Cancer: Exploring Current Knowledge and Advancing Understanding of This Understudied Disease.

    Providence medical breast oncologist to give a special presentation on Lobular Breast Cancer and the latest data on the development of a lobular prevention vaccine.

    Read Article
  • Next generation therapy for men with mCRPC may extend survival

    Next generation therapy for men with mCRPC may extend survival

    A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.

    Read Article
  • Behind the science: Celebrating our cancer research administrator

    Behind the science: Celebrating our cancer research administrator

    Get a behind the scenes peek into the work of a cancer research administrator as she reflects on her time at Providence Cancer Institute.

    Read Article
  • Charting new paths in treating ovarian cancer and recurring SCLC

    Charting new paths in treating ovarian cancer and recurring SCLC

    Two new trials evaluating new medications or combinations of medications for people with ovarian cancer or small cell lung cancer open at Providence Cancer Institute.

    Read Article
  • The future of surgery is robotic, and it’s here

    The future of surgery is robotic, and it’s here

    Robotic thoracic surgery is less invasive, allowing patients to recover more quickly. A Providence Cancer Institute surgeon calls it a game-changer.

    Read Article
  • Meet the 2025 cancer research interns

    Meet the 2025 cancer research interns

    Hands-on experience in a laboratory at Providence Cancer Institute helps undergraduate students find their career path in biomedical fields.

    Read Article
  • Watch: Virtual health talk on understanding lung cancer

    Watch: Virtual health talk on understanding lung cancer

    Learn key facts about lung cancer at a free virtual talk hosted by Providence Cancer Institute and Asian Cancer Resource & Support Services.

    Read Article
  • A new cancer therapy at Providence helps immune cells stand their ground

    A new cancer therapy at Providence helps immune cells stand their ground

    A new medication developed at Providence Cancer Institute is being evaluated in a clinical trial for people with advanced cancers.

    Read Article
  • A new generation CDK4 inhibitor study for people with HR+ HER2- breast cancer

    A new generation CDK4 inhibitor study for people with HR+ HER2- breast cancer

    A phase III clinical trial for people with HR+ HER2- breast cancer aims to extend survival and improve patients’ quality of life.

    Read Article
  • New Study: Providence whole genome sequencing program shows transformative potential for population health

    New Study: Providence whole genome sequencing program shows transformative potential for population health

    Published in Nature NPJ Genomic Medicine, Providence-led Geno4ME research program study highlights early detection, personalized prevention and prospect of improved care outcomes.

    Read Article
  • Cancer patients in Newberg receive a gift of comfort

    Cancer patients in Newberg receive a gift of comfort

    A generous gift of plush blankets helps comfort patients during their chemotherapy treatments at Providence Cancer Institute Newberg Clinic.

    Read Article
  • How cold cap therapy prevented patient’s hair loss during cancer treatment

    How cold cap therapy prevented patient’s hair loss during cancer treatment

    What surprised Molly most about cold cap therapy is that she didn’t lose her hair during treatment for breast cancer.

    Read Article
  • New Horizons in Immunotherapy for Cancer symposium: Collaborative cancer research

    New Horizons in Immunotherapy for Cancer symposium: Collaborative cancer research

    Expert voices in immuno-oncology from inside and outside Providence gather for a day of thought-provoking discussion, discovery and collaboration.

    Read Article
  • Providence researchers share cancer discoveries at 2025 ASCO meeting

    Providence researchers share cancer discoveries at 2025 ASCO meeting

    Explore new findings in cancer immunotherapy and clinical research from Providence at ASCO 2025.

    Read Article
  • Personalized mRNA vaccine and next-gen immunotherapy: Two new cancer trials at Providence

    Personalized mRNA vaccine and next-gen immunotherapy: Two new cancer trials at Providence

    Providence Cancer Institute is enrolling patients for two new immunotherapy trials targeting muscle-invasive urothelial cancer and advanced solid tumors.

    Read Article
  • loading
    Loading More...